![](https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2022/ep_us_feature_image_1221.jpeg)
EyePoint Pharmaceuticals (NASDAQ:EYPT) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement.
Analysts estimate that EyePoint Pharmaceuticals will report an earnings per share (EPS) of $-0.53.
EyePoint Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Historical Earnings Performance
Last quarter the company missed EPS by $0.18, which was followed by a 7.4% increase in the share price the next day.
Here's a look at EyePoint Pharmaceuticals's past performance and the resulting price change:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.40 | -0.43 | -0.46 | -0.17 |
EPS Actual | -0.58 | -0.42 | -0.50 | -1 |
Price Change % | 7.4% | 4.71% | -11.8% | -1.67% |
![](https://www.benzinga.com/files/images/story/2022/1646240531_0.png)
Stock Performance
Shares of EyePoint Pharmaceuticals were trading at $9.8 as of March 01. Over the last 52-week period, shares are up 2.81%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.